CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation

GRANJA-GALEANO, GINA; RUBIO, ANA PAULA DOMINGUEZ; ZAPPIA, C DANIEL; WOLFSON, MANUEL; SANZ BLASCO, SARA ; AISEMBERG, JULIETA; ZUBILETE, MARIA ZORRILLA; FERNANDEZ, NATALIA; FRANCHI, ANA; FITZSIMONS, CARLOS P.; MONCZOR, FEDERICO

NEUROPHARMACOLOGY

PERGAMON-ELSEVIER SCIENCE LTD

Año: 2023

0028-3908

The molecular processes that underlie long-term memory formation involve signaling pathway activation by neurotransmitter release, which induces the expression of immediate early genes, such as Zif268, having a key role in memory formation. In this work, we show that the cannabinoid CB1 receptor signaling is necessary for the effects of dexamethasone on the behavioral response in an inhibitory avoidance task, on dexamethasone-induced ERK phosphorylation, and on dexamethasone-dependent Zif268 expression. Furthermore, we provide primary evidence for the mechanism responsible for this crosstalk between cannabinoid and glucocorticoid-mediated signaling pathways, showing that dexamethasone regulates endocannabinoid metabolism by inhibiting the activity of the Fatty acid amide hydrolase (FAAH), an integral membrane enzyme that hydrolyzes endocannabinoids and related amidated signaling lipids. Our results provide novel evidence regarding the role of the endocannabinoid system, and in particular of the CB1 receptor, as a mediator of the effects of glucocorticoids on the consolidation of aversive memories.